Model of the developing tumorigenic phenotype in mammalian cells and the roles of sustained stress and replicative senescence.
暂无分享,去创建一个
[1] R. DePinho,et al. Telomere-based crisis: functional differences between telomerase activation and ALT in tumor progression. , 2003, Genes & development.
[2] B. Hall,et al. Adaptive mutations in Escherichia coli as a model for the multiple mutational origins of tumors. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[3] M. Z. Humayun,et al. SOS and Mayday: multiple inducible mutagenic pathways in Escherichia coli , 1998, Molecular microbiology.
[4] B. Bridges. Starvation-associated mutation in Escherichia coli: a spontaneous lesion hypothesis for "directed" mutation. , 1994, Mutation research.
[5] R. Chetty,et al. Cyclin E in human cancers , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[6] B. Ames,et al. The causes and prevention of cancer: gaining perspective. , 1997, Environmental health perspectives.
[7] T. Helleday,et al. Different Roles for Nonhomologous End Joining and Homologous Recombination following Replication Arrest in Mammalian Cells , 2002, Molecular and Cellular Biology.
[8] R. DePinho,et al. p19(Arf) induces p53-dependent apoptosis during abelson virus-mediated pre-B cell transformation. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[9] B. Shilo,et al. Regulation of cell number by MAPK-dependent control of apoptosis: a mechanism for trophic survival signaling. , 2002, Developmental cell.
[10] J. Roth,et al. Amplification–mutagenesis: Evidence that “directed” adaptive mutation and general hypermutability result from growth with a selected gene amplification , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[11] Y. Zou,et al. Oxidative stress activates extracellular signal-regulated kinases through Src and Ras in cultured cardiac myocytes of neonatal rats. , 1997, The Journal of clinical investigation.
[12] R. Woodgate. A plethora of lesion-replicating DNA polymerases. , 1999, Genes & development.
[13] M. Rao,et al. Neural stem cells and regulation of cell number , 2002, Progress in Neurobiology.
[14] Timothy K Starr,et al. Positive and negative selection of T cells. , 2003, Annual review of immunology.
[15] S. Wacholder,et al. Interpreting epidemiologic research: lessons from studies of childhood cancer. , 2003, Pediatrics.
[16] S. Kowalczykowski,et al. The DNA binding and pairing preferences of the archaeal RadA protein demonstrate a universal characteristic of DNA strand exchange proteins , 2000, Molecular microbiology.
[17] J. Overbaugh,et al. The origin of mutants , 1988, Nature.
[18] Z. Wang. DNA damage-induced mutagenesis : a novel target for cancer prevention. , 2001, Molecular interventions.
[19] L. Chin,et al. Telomere dysfunction provokes regional amplification and deletion in cancer genomes. , 2002, Cancer cell.
[20] R. Dickson,et al. c-Myc alters the DNA damage-induced G2/M arrest in human mammary epithelial cells , 2003, British Journal of Cancer.
[21] R. Abe,et al. Enhancement of macrophage migration inhibitory factor (MIF) expression in injured epidermis and cultured fibroblasts. , 2000, Biochimica et biophysica acta.
[22] J. Sample,et al. Epstein-Barr Virus Regulates c-MYC, Apoptosis, and Tumorigenicity in Burkitt Lymphoma , 1999, Molecular and Cellular Biology.
[23] S. R. Datta,et al. Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. , 1999, Science.
[24] R. Schaaper,et al. Genetic requirements and mutational specificity of the Escherichia coli SOS mutator activity , 1997, Journal of bacteriology.
[25] E. Blackburn,et al. Telomeres, telomerase and cancer. , 1996, Scientific American.
[26] R. Margolis,et al. Chemical induction of mitotic checkpoint override in mammalian cells results in aneuploidy following a transient tetraploid state. , 1996, Mutation research.
[27] W. Morgan,et al. Polymerase eta deficiency in the xeroderma pigmentosum variant uncovers an overlap between the S phase checkpoint and double-strand break repair. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[28] David Botstein,et al. Characteristic genome rearrangements in experimental evolution of Saccharomyces cerevisiae , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[29] G. Carruba,et al. Growth of LNCaP human prostate cancer cells is stimulated by estradiol via its own receptor. , 1995, Endocrinology.
[30] W C Willett,et al. The causes and prevention of cancer. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[31] Mark J. Murphy,et al. c-Myc regulates mammalian body size by controlling cell number but not cell size , 2001, Nature.
[32] G. Evan,et al. Proliferation, cell cycle and apoptosis in cancer , 2001, Nature.
[33] S. Korsmeyer,et al. Apoptosis in the development and maintenance of the immune system , 2003, Nature Immunology.
[34] Kenneth J. Hillan,et al. Angiogenesis-Independent Endothelial Protection of Liver: Role of VEGFR-1 , 2003, Science.
[35] R. Weinberg,et al. Ras modulates Myc activity to repress thrombospondin-1 expression and increase tumor angiogenesis. , 2003, Cancer cell.
[36] S. Kowalczykowski,et al. DNA strand exchange proteins: a biochemical and physical comparison. , 1998, Frontiers in bioscience : a journal and virtual library.
[37] Yanbin Zhang,et al. Two-step error-prone bypass of the (+)- and (−)-trans-anti-BPDE-N2-dG adducts by human DNA polymerases η and κ , 2002 .
[38] P. Pandolfi,et al. Activation of Akt/Protein Kinase B Overcomes a G2/M Cell Cycle Checkpoint Induced by DNA Damage , 2002, Molecular and Cellular Biology.
[39] R. Zeillinger,et al. Role of p53 in G2/M cell cycle arrest and apoptosis in response to gamma-irradiation in ovarian carcinoma cell lines. , 2003, International journal of oncology.
[40] B. Amati,et al. Cyclin E and c‐Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteins , 1997, The EMBO journal.
[41] L. Harrington,et al. Telomeres, telomerase, and cancer: life on the edge of genomic stability , 2000, Current opinion in oncology.
[42] Localisation of human DNA polymerase κ to replication foci , 2002, Journal of Cell Science.
[43] L. Stanton,et al. Synergism of v-myc and v-Ha-ras in the in vitro neoplastic progression of murine lymphoid cells , 1986, Molecular and cellular biology.
[44] J. Pietenpol,et al. Cell cycle checkpoint signaling: cell cycle arrest versus apoptosis. , 2002, Toxicology.
[45] C. Der,et al. Understanding Ras: 'it ain't over 'til it's over'. , 2000, Trends in cell biology.
[46] Pascal Meier,et al. Apoptosis in development , 2000, Nature.
[47] N. Rosenberg,et al. p53 Mediates Apoptotic Crisis in Primary Abelson Virus-Transformed Pre-B Cells , 1999, Molecular and Cellular Biology.
[48] J. Sedivy,et al. A modest reduction in c-myc expression has minimal effects on cell growth and apoptosis but dramatically reduces susceptibility to Ras and Raf transformation. , 2001, Cancer research.
[49] N. Restifo,et al. Natural selection of tumor variants in the generation of “tumor escape” phenotypes , 2002, Nature Immunology.
[50] Martin Raff,et al. Cell suicide for beginners , 1998, Nature.
[51] D. Dykhuizen. Chemostats used for studying natural selection and adaptive evolution. , 1993, Methods in enzymology.
[52] P. Hall,et al. Regulation of cell number in the mammalian gastrointestinal tract: the importance of apoptosis. , 1994, Journal of cell science.
[53] L. Vatten,et al. Prospective study of colorectal cancer risk and physical activity, diabetes, blood glucose and BMI: exploring the hyperinsulinaemia hypothesis , 2001, British Journal of Cancer.
[54] J. Shay,et al. Telomeres and Telomerase: Implications for Cancer and Aging , 2001, Radiation research.
[55] R. Eisenman,et al. The Myc/Max/Mad network and the transcriptional control of cell behavior. , 2000, Annual review of cell and developmental biology.
[56] E. Ortega,et al. Oncogenic H-ras induces cyclin B1 expression in a p53-independent manner. , 2002, Mutation research.
[57] N. Yamada,et al. Induction of a low level of microsatellite instability by overexpression of DNA polymerase Beta. , 2002, Cancer research.
[58] Robert A. Weinberg,et al. Creation of human tumour cells with defined genetic elements , 1999, Nature.
[59] C. Lawrence,et al. Eukaryotic mutagenesis and translesion replication dependent on DNA polymerase ζ and Rev I protein , 2001 .
[60] C. Longcope,et al. Serum sex hormones and breast cancer risk factors in postmenopausal women. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[61] W. Coleman,et al. The Molecular Basis of Human Cancer , 2002, Humana Press.
[62] D. Stupack,et al. Role of Raf in Vascular Protection from Distinct Apoptotic Stimuli , 2003, Science.
[63] T. Kunkel,et al. Functions of human DNA polymerases η, κ and ι suggested by their properties, including fidelity with undamaged DNA templates , 2003 .
[64] S. Rodin,et al. Human lung cancer and p53: the interplay between mutagenesis and selection. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[65] R. Weinberg,et al. Behavior of myc and ras oncogenes in transformation of rat embryo fibroblasts , 1986, Molecular and cellular biology.
[66] L. Mullenders,et al. Domain structure, localization, and function of DNA polymerase eta, defective in xeroderma pigmentosum variant cells. , 2001, Genes & development.
[67] F. McCormick,et al. Opposing Effects of Ras on p53 Transcriptional Activation of mdm2 and Induction of p19ARF , 2000, Cell.
[68] S. Rosenberg,et al. Adaptive mutations, mutator DNA polymerases and genetic change strategies of pathogens. , 2001, Current opinion in microbiology.
[69] Rey-Huei Chen,et al. Molecular interpretation of ERK signal duration by immediate early gene products , 2002, Nature Cell Biology.
[70] Sergey V. Balashov,et al. Mistranslation induced by streptomycin provokes a RecABC/RuvABC-dependent mutator phenotype in Escherichia coli cells. , 2002, Journal of molecular biology.
[71] D. Laskin,et al. The ribotoxic stress response as a potential mechanism for MAP kinase activation in xenobiotic toxicity. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.
[72] N. Mailand,et al. Involvement of Myc Activity in a G1/S-Promoting Mechanism Parallel to the pRb/E2F Pathway , 2000, Molecular and Cellular Biology.
[73] M. Goodman. Error-prone repair DNA polymerases in prokaryotes and eukaryotes. , 2002, Annual review of biochemistry.
[74] C. Kisker,et al. Error-Prone DNA Polymerases Novel Structures and the Benefits of Infidelity , 2001, Cell.
[75] D. Sharma,et al. MODULATION OF C‐ MYC AND C‐ FOS GENE EXPRESSION IN REGENERATING RAT LIVER BY 2‐MERCAPTOPROPIONYLGLYCINE , 2002, Cell biology international.
[76] F. O. Fackelmayer,et al. DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. , 2001, Cancer research.
[77] J. Steitz,et al. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. , 1992, The EMBO journal.
[78] D. Green,et al. The machinery of programmed cell death. , 2001, Pharmacology & therapeutics.
[79] Chikahide Masutani,et al. Low fidelity DNA synthesis by human DNA polymerase-η , 2000, Nature.
[80] S. Reed,et al. Cyclin E-induced S phase without activation of the pRb/E2F pathway. , 1997, Genes & development.
[81] C. Der,et al. Increasing complexity of Ras signal transduction: involvement of Rho family proteins. , 1998, Advances in cancer research.
[82] M. Merville,et al. Roles of nuclear factor-kappaB, p53, and p21/WAF1 in daunomycin-induced cell cycle arrest and apoptosis. , 2000, The Journal of pharmacology and experimental therapeutics.
[83] G. Nossal. The double helix and immunology , 2003, Nature.